Smad3-null mice lack interstitial cells of Cajal in the colonic wall

European Journal of Clinical Investigation

Volumn 36, Issue 1, 2006, Pages 41-48

  Vetuschi, A ^a   Sferra, R ^a   Latella, G ^a,c   D'Angelo, A ^a   Catitti, V ^a   Zanninelli, G ^a   Con Tinenza, M A ^a   Gaudio, E ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

C Kit; Colon; Interstitial cells of Cajal; Smads; Smooth muscle; TGF

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DESMIN; EOSIN; HEMATOXYLIN; NEUROFILAMENT PROTEIN; PROTEIN ANTIBODY; PROTEIN S 100; SMAD3 PROTEIN; STEM CELL FACTOR; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON; COLON DILATATION; CONTROLLED STUDY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERSTITIAL CELL OF CAJAL; INTESTINE MUSCLE; MORPHOMETRICS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SILVER STAINING; STATISTICAL SIGNIFICANCE; WILD TYPE;

ANIMALS; COILED BODIES; COLON; DILATATION, PATHOLOGIC; IMMUNOENZYME TECHNIQUES; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; MUSCLE, SMOOTH; PHENOTYPE; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 33645071313     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2006.01593.x     Document Type: Article

References (74)

1. Snape WJ Williams R Hyman PE Defect in colonic muscle contraction in patients with ulcerative colitis Am J Physiol Gastroinest Liver Physiol 1991 261 G987 95
2. Reddy SN Bazzocchi G Chan S Akashi K Villanueva-Meyer J Yanni G et al. Colonic motility and transit in health and ulcerative colitis Gastroenterology 1991 101 1289 97
3. Tomita R Tanjoh K Fujisaki S Fukuzawa M Peptidergic nerves in the colon of patients with ulcerative colitis Hepato-gastroenterol 2000 47 400 4
4. Vrees MD Pricolo VE Potenti FM Cao W Abnormal motility in patients with ulcerative colitis: the role of inflammatory cytokines Arch Surg 2002 137 439 45
5. Neunlist M Aubert P Toquet C Oreshkova T Barouk J Lehur PA et al. Changes in chemical coding of myenteric neurones in ulcerative colitis Gut 2003 52 84 90
6. Lomax AE Fernandez E Sharkey KA Plasticity of the enteric nervous system during intestinal inflammation Neurogastroenterol Motil 2005 17 4 15
7. Jacobson K McHugh K Collins SM Experimental colitis alters myoenteric nerve function of inflamed and non-inflamed sites Gastroenterology 1995 109 718 22
8. Sanovic S Lamb DP Blennerhassett MG Damage to the enteric nervous system in experimental colitis Am J Pathol 1999 155 1051 7
9. Latella G Vernia P Viscido A Frieri G Cadau G Cocco A et al. GI distension in severe ulcerative colitis Am J Gastroenterol 2002 97 1169 75
10. Sanders KM Ordog T Ward SM Physiology and pathophysiology of the interstitial cells of cajal: from bench to bedside. IV. Genetic and animal models of GI motility disorders caused by loss of interstitial cell of Cajal Am J Physiol Gastrointest Liver Physiol 2002 282 G747 56
11. Cajal SR Sur les ganglions et plexus nerveux de l'intestin CR Soc Biol (Paris) 1893 45 217 23
12. Cajal SR Histologie du system nerveux de l'homme et des vertebres: grand sympathic vol. 2 Paris Maloine 1911 891 942
13. Young HM Ciampoli D Johnson PJ Stebbing MJ Origin of interstitial cells of Cajal in the mouse intestine Dev Biol 1996 180 97 107
14. Faussone-Pellegrini SM Thuneberg L Guide to the identification of interstitial cells of Cajal Microsc Res Techniq 1999 47 249 66
15. Thuneberg L One hundred years of interstitial cells of Cajal Microsc Res Techniq 1999 47 223 38
16. Torihashi S Yokoi K Nagaya K Aoki K Fujimoto T New monoclonal antibody (AIC) identifies interstitial cells of Cajal in the musculature of the mouse intestinal tract Auton Neurosci 2004 113 16 23
17. Powell DW Mifflin RC Valentich JD Crowe SE Saada JI West AB Myofibroblasts I. Paracrine cells important in health and disease Am J Physiol Cell Physiol 1999 277 C1 19
18. Powell DW Mifflin RC Valentich JD Crowe SE Saada JI West AB Myofibroblasts II. Intestinal subepithelial myofibroblasts Am J Physiol Cell Physiol 1999 277 C183 201
19. Huizinga JD Thuneberg L Kluppel M Malysz J Mikkelson HB Bernstein A W/kit required for interstitial cells of Cajal and for intestinal pacemaker activity Nature 1995 373 347 9
20. Sanders KM A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract Gastroenterology 1996 111 492 515
21. Pucilowska JB Williams KL Lund PK Fibrogenesis IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models Am J Physiol Gastroinest Liver Physiol 2000 279 G653 9
22. Schuppan D Koda M Hahn EG Fibrosis of liver, pancreas and intestine: common mechanisms and clear targets? Acta Gastroenterol Belg 2000 63 366 70
23. Van Assche G Can we influence fibrosis in Crohn's disease? Acta Gastroenterol Belg 2001 64 193 6
24. Huizinga JD Neural injury, repair and adaptation in the GI tract IV. Pathophysiology of GI motility related to interstitial cells of Cajal Am J Physiol Gastroinest Liver Physiol 1998 275 G381 6
25. Vanderwinden JM Rumessen JJ Interstitial cells of Cajal in human gut and gastrointestinal disease Microsc Res Techniq 1999 47 344 60
26. Ward SM Gershon MD Keef K Bayguinov YR Nelson C Sanders KM Interstitial cells of Cajal and electrical activity in ganglionic and aganglionic colons of mice Am J Physiol Gastroinest Liver Physiol 2002 283 G445 56
27. Rumessen JJ Ultrastructure of interstitial cells of Cajal at the colonic submuscular border in patients with ulcerative colitis Gastroenterology 1996 111 1447 55
28. Porcher C Baldo M Henry M Orsoni P Jule Y Ward SM Deficiency of interstitial cells of Cajal in the small intestine of patients with Crohn's disease Am J Gastroenterol 2002 97 118 25
29. Chen S Lechleider RJ Transforming growth factor-beta-induced differentiation of smooth muscle from a neural crest stem cell line Circ Res 2004 94 1195 202
30. Sinha S Hoofnagle MH Kingston PA McCanna ME Owens GK Transforming growth factor-beta 1 signalling contributes to development of smooth muscle cell from embryonic stem cells Am J Physiol Cell Physiol 2004 287 C1560 8
31. Chegini N Luo X Ding L Ripley D The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropinn releasing hormone analogue therapy Mol Cell Endocrinol 2003 209 9 16
32. Ikedo H Tamaki K Ueda S Kato S Fujii M Ten Dijke P et al. Smad protein and TGF-beta signalling in vascular SMC Int J Mol Med 2003 11 645 50
33. Hu B Wu Z Phan SH Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression Am J Respir Cell Mol Biol 2003 29 397 404
34. Ward SM Ordog T Bayguinow JR Horowitz B Epperson A Shen L et al. Development of interstitial cells of Cajal and pace-making in mice lacking enteric nerves Gastroenteroogy 1999 117 584 94
35. Elson CO Con g Y Brandwein S Weaver CT McCabe RP Mahler M et al. Experimental models to study molecular mechanisms underlying intestinal inflammation Ann NY Acad Sci 1998 859 85 95
36. Ward SM Burns AJ Torihashi S Sanders KM Mutation of the proto-oncogene c-kit blocks development of interstitial cells and electrical rhythmicity in murine intestine J Physiol 1994 480 91 7
37. Ward SM Burns AJ Torihashi S Harney SC Sanders KM Impaired development of interstitial cells and intestinal electrical rhythmicity in steel mutants Am J Physiol Cell Physiol 1995 269 C1577 85
38. Weinstein M Yang X Deng C Functions of mammalian Smad genes as revealed by targeted gene disruption in mice Cytokine Growth Factor Rev 2000 11 49 58
39. Goumans MJ Mummery C Functional analysis of the TGF-beta receptor/Smad pathway through gene ablation in mice Int J Dev Biol 2000 44 253 65
40. Shi Y Massague J Mechanisms of TGF-beta signalling from cell membrane to the nucleus Cell 2003 113 685 700
41. Derynck R Zhang YE Smad-dependent and Smad-independent pathways in TGF-β family signalling Nature 2003 425 577 84
42. Roberts AB Russo A Felici A Flanders KC Smad3: a key player in pathogenetic mechanisms dependent TGF-beta Ann NY Acad Sci 2003 995 1 10
43. Verrecchia F Mauviel A Transforming growth factor-beta signalling through the Smads pathway. role in extra-cellular matrix gene expression and regulation J Invest Dermatol 2002 118 211 5
44. Wells RG Fibrogenesis V TGF-β signaling pathways Am J Physiol Gastroinest Liver Physiol 2000 279 G845 50
45. Monteleone G Kumberova A Croft NM McKenzie C Steer HW MacDonald TT Blocking Smad7 restores TGFβ1 signaling in chronic inflammatory bowel disease J Clin Invest 2001 108 601 9
46. Hahm KB Im YH Parks TW Markowitz S Jung HY Green J et al. Loss of transforming growth factor β signaling in the intestine contributes to tissue injury in inflammatory bowel disease Gut 2001 49 190 8
47. Schull MM Ormsby I Kier AB Pawlowski S Diebold RJ Yin M et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease Nature 1992 359 693 9
48. Kulkarni AB Huh CG Becker D Geiser A Lyght M Flanders KC et al. Transforming growth factor beta-1 null mutation in mice causes excessive inflammatory response and early death Proc Natl Acad Sci USA 1993 90 770 4
49. Bottinger EP Letterio JJ Roberts AB Biology of TGF-β and transgenic mouse models Kidney Int 1997 51 1355 60
50. Nomura M Li E Smad2 role in mesoderm formation, left-right patterning and craniofacial development Nature 1998 393 786 90
51. Yang X Li C Hu X Deng C The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice Proc Natl Acad Sci USA 1998 95 3667 72
52. Yang X Letterio JJ Lechleider RJ Chen L Hayman R Gu H et al. Targeted disruption of Smad3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta EMBO J 1999 18 1280 91
53. Datto MB Frederick JP Pan L Borton AJ Zhuang Y Wang XF Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction Mol Cell Biol 1999 19 2495 504
54. Zhu Y Richardson JA Parada LF Graff JM Smad3 mutant mice develop metastatic colorectal cancer Cell 1998 94 703 14
55. Ashcroft GS Roberts AB Loss of Smad3 modulates wound healing Cytokine Growth Factor Rev 2000 11 125 31
56. Flanders K Sullivan CD Fuji M Sowers A Anzano M Arabshahi A et al. Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation Am J Pathol 2002 160 1057 68
57. Lakos G Tacagawa S Chen SJ Ferreira AM Han G Wang XJ et al. Targeted disruption of TGF-beta/Smad3 signalling modulates skin fibrosis in a mouse model of scleroderma Am J Pathol 2004 165 203 17
58. Zhao J Shi W Wang YL Chen H Bringas P Datto MB et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice Am J Physiol Lung Cell Mol Physiol 2002 282 L585 93
59. Schnabl B Kweon YO Frederick JP Wang XF Rippe RA Brenner DA The role of Smad3 in mediating mouse hepatic stellate cell activation Hepatology 2001 34 89 100
60. Fujimoto M Maezawa Y Yokote K Kobayashi K Kawamura H Nishimura M et al. Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy Biochem Biophys Res Commun 2003 305 1002 7
61. Inazaki K Kanamaru Y Kojima Y Sueyoshi N Okumura K Kaneko K et al. Smad3 deficiency attenuates renal fibrosis, inflammation and apoptosis after unilateral ureteral obstruction Kidney Int 2004 66 597 604
62. Wang W Koka V Lan HY Transforming growth factor-beta and Smad signalling in kidney diseases Nephrology 2005 10 48 56
63. Flanders KC Smad3 as a mediator of the fibrotic response Int J Exp Pathol 2004 85 47 64
64. Zanninelli G Vetuschi A Sferra R D'Angelo A Chiaramonte M Gaudio E et al. Smad3 knock-out mice as a tool to study chronic intestinal inflammation and fibrosis Digest Liver Dis 2005 37 Suppl. 1 S46
65. Zanninelli G Vetuschi A Sferra R D'Angelo A Fratticci A Con tinenza A et al. Smad3 knock-out mice as a useful model to study intestinal fibrogenesis World J Gastroenterol 2005, in press
66. Neurath M Fuss I Kelsall B Strober W Antibodies to interleukin-12 abrogate established experimental colitis in mice J Exp Med 1995 182 1281 90
67. Hotchkiss RS Swanson PE Cobb JP Jacobson A Buchman TG Karl IE Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice Crit Care Med 1997 25 1298 307
68. Torihashi S Horisawa M Watanabe Y C-kit immunoreactive interstitial cells in the human gastrointestinal tract J Auton Nerv Syst 1999 75 38 50
69. Torihashi S Nishi K Tokutomi Y Nishi T Ward S Sanders KM Blockade of kit signalling induces transdifferentiation of interstitial cells of Cajal to a smooth muscle phenotype Gastroenterology 1999 117 140 8
70. Miettinen M Lasota J Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical and molecular genetic features and differential diagnosis Virchows Arch 2001 438 1 12
71. Strickland L Letson GD Muro-Cacho CA Gastrointestinal stromal tumors Cancer Control 2001 8 252 61
72. Berman J O'Leary TJ Gastrointestinal stromal tumor workshop Hum Pathol 2001 32 578 82
73. Nagarajan RP Liu J Chen Y Smad3 inhibits transforming growth factor-beta and activin signalling by competing with Smad4 for FASDT-2 binding J Biol Chem 1999 274 31229 35
74. Hayes SA Zarnegar M Sharma M Yang F Peehl D Ten Dijke P et al. Smad3 represses androgen receptor-mediated transcription Cancer Res 2001 61 2112 8